Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000932471-25-000369·NEUROCRINE BIOSCIENCES INC
Schedule 13G ownership disclosure
NEUROCRINE BIOSCIENCES INC COM
Common Stock · CUSIP: 64125C109
Event date: 2025-02-28
- Filing-level shares
- 10,129,687
- Percent of class
- 10.15%
- The Vanguard Group
Shares: 10,129,687 · Class: 10.15%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000369
- Form type
- SCHEDULE 13G/A
- Filer
- NEUROCRINE BIOSCIENCES INC
- CIK
- CIK 914475
- Filed
- Mar 06, 2025
- Reporting period
- Feb 28, 2025
- Description
- Schedule 13G beneficial ownership